Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Glory Yorke

Physician Assistant, Medical Las Vegas, NV Physician Assistant

NPI 1447569363 CMS profile 10445632

4100 W Flamingo Rd, Las Vegas, NV 89103

Open in the dashboard

General payments

$6,883

236 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Glory Yorke of Las Vegas, NV is reported in the CMS Open Payments database as having received $6,883 across 236 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,339 44
2024 General $1,955 69
2023 General $1,158 51
2022 General $814 37
2021 General $1,616 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Glory Yorke
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Glory Yorke were reported at $1,339. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Glory Yorke Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $1,616 $156 $41–$563 $132
2022 $814 $185 $55–$649 $149
2023 $1,158 $199 $58–$717 $160
2024 $1,955 $206 $62–$740 $164
2025 $1,339 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AstraZeneca Pharmaceuticals LP $1,918 64 payments
  2. Novo Nordisk Inc $1,350 65 payments
  3. Biohaven Pharmaceuticals, Inc. $835 5 payments
  4. AbbVie, Inc. $548 16 payments
  5. Amgen Inc. $474 10 payments
  6. Bayer HealthCare Pharmaceuticals Inc. $413 15 payments
  7. Abbott Laboratories $251 10 payments
  8. Lilly USA, LLC $219 14 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $179 7 payments
  10. GlaxoSmithKline, LLC. $132 6 payments
  11. Other $563 24 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,993 234 payments
  2. Consulting Fee $800 1 payment
  3. Education $90 1 payment
Products named General payments · program years 2021–2025
  1. NURTEC ODT $1,014 12 payments
  2. FARXIGA $921 33 payments
  3. RYBELSUS $689 35 payments
  4. Ozempic $591 34 payments
  5. UBRELVY $548 16 payments
  6. KRYSTEXXA $474 10 payments
  7. AIRSUPRA $442 17 payments
  8. Kerendia $413 15 payments
  9. QULIPTA $386 9 payments
  10. BREZTRI $361 13 payments
  11. Other $2,028 102 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

236 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record